|
Intangible Asset License - Additional Information (Detail) (USD $)
|
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Indefinite-lived Intangible Assets [Line Items] | ||
| Payments to Acquire Intangible Assets | $ 1,250,000us-gaap_PaymentsToAcquireIntangibleAssets | $ 0us-gaap_PaymentsToAcquireIntangibleAssets |
| Journey Medical Corporation [Member] | ||
| Indefinite-lived Intangible Assets [Line Items] | ||
| Payments to Acquire Intangible Assets |
1,200,000us-gaap_PaymentsToAcquireIntangibleAssets / us-gaap_RelatedPartyTransactionAxis = fbio_JourneyMedicalCorporationMember |
|
| License Costs |
$ 700,000us-gaap_LicenseCosts / us-gaap_RelatedPartyTransactionAxis = fbio_JourneyMedicalCorporationMember |
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|